Delivery Order 36C26324D0048-36C26324N0502

Award Date 2/15/24
Potential Completion Date 9/30/24
Potential Value $113K
Ultimate Awardee
Becton, Dickinson & Co
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Jose, CA 95131, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Walsh Healy Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 23 (VISN 23), a division of the U.S. Department of Veterans Affairs (VA), to Becton, Dickinson and Company (BD), a global medical technology company. The $270,407.50 contract is for the supply of flow cytometry reagents to the Minneapolis VA Medical Center. The contract has a period of performance through September 30, 2025. BD, the prime contractor, is a manufacturer of medical devices,...
This federal contract award is for BECTON DICKINSON FLOW CYTOMETRY REAGENTS AND SUPPLIES to Becton, Dickinson And Company (BD), a global medical technology company. The contract, awarded by the Veterans Integrated Service Network 16 (VISN 16) of the U.S. Department of Veterans Affairs (VA), has a value of $48,551.20 and is a Blanket Purchase Agreement (BPA) call with a firm-fixed price pricing type. The contract has a completion date of September 30, 2025 and was awarded on October 1, 2023. BD...
This federal contract award to Becton, Dickinson and Company (BD), a global medical technology company, was issued by the U.S. Department of Veterans Affairs (VA) for the provision of flow cytometry supplies. The contract has a ceiling value of $81,737.07 and was awarded on October 1, 2019, with a period of performance ending on September 30, 2020. The contract is a delivery order with a firm fixed price pricing type, and it does not have a set-aside designation. BD, through its BD Biosciences...
This is a $313,104.48 firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA), Veterans Integrated Service Network 5, to Becton, Dickinson and Company (BD) for the provision of flow cytometry reagents and supplies for the Washington, DC VA Medical Center. The contract does not have a set-aside designation, indicating that BD, a large manufacturer of medical devices and laboratory equipment, was competitively selected. BD, through its BDB Division and BD...
This federal contract award to Becton, Dickinson and Company (BD) is for the provision of flow cytometry reagents and supplies. The contract has a ceiling value of $139,757.50 and a completion date of November 29, 2025. It was awarded on November 30, 2024 by the Veterans Integrated Service Network 5 (VISN 5), a division of the U.S. Department of Veterans Affairs (VA). This award does not have a set-aside designation. BD is a global medical technology company that develops, manufactures, and...
This federal contract award, valued at $82,760.81, was issued by the Veterans Integrated Service Network 1 of the U.S. Department of Veterans Affairs (VA) to Becton, Dickinson and Company (BD), a global medical technology company. The contract is for the delivery of flow cytometry supplies, which are specialized laboratory equipment and consumables used to analyze and sort cells. The contract is a delivery order under a larger indefinite delivery/indefinite quantity (IDIQ) contract vehicle...
This federal contract award is for the procurement of a flow cytometer by the Department of Veterans Affairs (VA) Veterans Health Administration. The contract was awarded to Becton, Dickinson and Company (BD), a global medical technology company, specifically its BD Biosciences division which focuses on biomedical research and clinical applications through flow cytometry, cell imaging, and genomics technologies. The contract has a firm fixed price of $486,733.62 and was awarded on May 10,...
This contract award to Becton, Dickinson and Company (BD), a global medical technology manufacturer, is for the provision of flow cytometry reagents and consumables to the U.S. Department of Veterans Affairs (VA) through a Blanket Purchase Agreement (BPA) call. The contract has a ceiling value of $107,233.63 and an ultimate completion date of January 14, 2024. BD, through its BD Biosciences division, is a well-established supplier of flow cytometry equipment, reagents, and related laboratory...
The Department of Veterans Affairs Veterans Health Administration awarded a definitive, firm fixed-price contract valued at $206,782.20 to Becton, Dickinson And Company (BD) for a flow cytometry system and reagents. This award is not set aside for any specific business category. BD is a global medical technology company that provides instruments, reagents, and services supporting biomedical research and clinical applications, including extensive prior contracts with the VA and other federal...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded a $122,000 firm fixed price blanket purchase agreement call contract to Becton, Dickinson and Company for flow cytometry reagents and consumables. BD Biosciences, a division of Becton, Dickinson and Company, will deliver the requested products to support flow cytometry activities in Boston, Massachusetts through January 2025. No set aside designation was applied to this contract...
  • 36C26324D0048
    Indefinite Delivery Contract
  • 36C26324D0048-36C26324N0502
    Delivery Order

This federal contract award is for the procurement of flow cytometry reagents by the Veterans Integrated Service Network 23 (VISN 23) on behalf of the Minneapolis VA Medical Center. The contract was awarded to Becton, Dickinson and Company (BD), a global medical technology company that specializes in flow cytometry and related biomedical instruments and supplies. The award, valued at $113,264.93, is for a firm-fixed-price delivery order with a period of performance through September 30, 2024. The contract does not have a set-aside designation. BD, through its BD Biosciences division, is a major supplier of flow cytometry equipment, reagents, and services to various federal agencies, including the VA, National Institutes of Health, and Department of Defense, supporting biomedical research and clinical applications.

Generated 3/18/25, 9:44 AM